nodes	percent_of_prediction	percent_of_DWPC	metapath
Midazolam—ABCB1—ovarian cancer	0.255	1	CbGaD
Midazolam—CYP3A7-CYP3A51P—Paclitaxel—ovarian cancer	0.0431	0.103	CbGbCtD
Midazolam—CYP3A7—Paclitaxel—ovarian cancer	0.0431	0.103	CbGbCtD
Midazolam—ABCB1—Topotecan—ovarian cancer	0.0425	0.102	CbGbCtD
Midazolam—CYP3A5—Paclitaxel—ovarian cancer	0.0323	0.0773	CbGbCtD
Midazolam—CYP3A7—Docetaxel—ovarian cancer	0.0312	0.0745	CbGbCtD
Midazolam—CYP3A7-CYP3A51P—Docetaxel—ovarian cancer	0.0312	0.0745	CbGbCtD
Midazolam—ABCB1—Vinorelbine—ovarian cancer	0.03	0.0716	CbGbCtD
Midazolam—CYP3A4—Topotecan—ovarian cancer	0.0255	0.0609	CbGbCtD
Midazolam—CYP3A5—Docetaxel—ovarian cancer	0.0234	0.0559	CbGbCtD
Midazolam—CYP2B6—Doxorubicin—ovarian cancer	0.0221	0.0529	CbGbCtD
Midazolam—ABCB1—Paclitaxel—ovarian cancer	0.021	0.0503	CbGbCtD
Midazolam—CYP3A4—Vinorelbine—ovarian cancer	0.0179	0.0429	CbGbCtD
Midazolam—ABCB1—Docetaxel—ovarian cancer	0.0152	0.0364	CbGbCtD
Midazolam—CYP3A4—Paclitaxel—ovarian cancer	0.0126	0.0301	CbGbCtD
Midazolam—ABCB1—Doxorubicin—ovarian cancer	0.0113	0.0271	CbGbCtD
Midazolam—CYP3A4—Docetaxel—ovarian cancer	0.00912	0.0218	CbGbCtD
Midazolam—CYP3A4—Doxorubicin—ovarian cancer	0.0068	0.0162	CbGbCtD
Midazolam—CYP4B1—uterine cervix—ovarian cancer	0.0029	0.0478	CbGeAlD
Midazolam—CYP4B1—decidua—ovarian cancer	0.00276	0.0456	CbGeAlD
Midazolam—CYP4B1—endometrium—ovarian cancer	0.00262	0.0433	CbGeAlD
Midazolam—CYP4B1—uterus—ovarian cancer	0.00242	0.0399	CbGeAlD
Midazolam—CYP4B1—female reproductive system—ovarian cancer	0.00217	0.0358	CbGeAlD
Midazolam—CYP4B1—female gonad—ovarian cancer	0.00198	0.0326	CbGeAlD
Midazolam—CYP4B1—vagina—ovarian cancer	0.00197	0.0324	CbGeAlD
Midazolam—CYP4B1—testis—ovarian cancer	0.00175	0.0289	CbGeAlD
Midazolam—GABRP—uterine cervix—ovarian cancer	0.00163	0.0269	CbGeAlD
Midazolam—GABRE—myometrium—ovarian cancer	0.0016	0.0264	CbGeAlD
Midazolam—GABRP—decidua—ovarian cancer	0.00156	0.0257	CbGeAlD
Midazolam—GABRP—endometrium—ovarian cancer	0.00148	0.0244	CbGeAlD
Midazolam—GABRG3—testis—ovarian cancer	0.00143	0.0235	CbGeAlD
Midazolam—GABRP—uterus—ovarian cancer	0.00136	0.0225	CbGeAlD
Midazolam—GABRR1—testis—ovarian cancer	0.00136	0.0224	CbGeAlD
Midazolam—CYP4B1—lymph node—ovarian cancer	0.00127	0.021	CbGeAlD
Midazolam—GABRE—uterine cervix—ovarian cancer	0.00125	0.0206	CbGeAlD
Midazolam—GABRB1—vagina—ovarian cancer	0.00124	0.0204	CbGeAlD
Midazolam—GABRP—female reproductive system—ovarian cancer	0.00122	0.0202	CbGeAlD
Midazolam—GABRE—decidua—ovarian cancer	0.00119	0.0196	CbGeAlD
Midazolam—GABRD—testis—ovarian cancer	0.00118	0.0195	CbGeAlD
Midazolam—GABRE—endometrium—ovarian cancer	0.00113	0.0186	CbGeAlD
Midazolam—GABRP—vagina—ovarian cancer	0.00111	0.0183	CbGeAlD
Midazolam—GABRA5—testis—ovarian cancer	0.0011	0.0181	CbGeAlD
Midazolam—GABRR2—lymph node—ovarian cancer	0.00102	0.0169	CbGeAlD
Midazolam—GABRA3—testis—ovarian cancer	0.00102	0.0168	CbGeAlD
Midazolam—GABRE—female reproductive system—ovarian cancer	0.000934	0.0154	CbGeAlD
Midazolam—GABRB3—gonad—ovarian cancer	0.000887	0.0146	CbGeAlD
Midazolam—GABRA2—vagina—ovarian cancer	0.000852	0.0141	CbGeAlD
Midazolam—GABRE—female gonad—ovarian cancer	0.00085	0.014	CbGeAlD
Midazolam—GABRE—vagina—ovarian cancer	0.000845	0.0139	CbGeAlD
Midazolam—GABRB2—testis—ovarian cancer	0.000832	0.0137	CbGeAlD
Midazolam—SLC22A1—vagina—ovarian cancer	0.000805	0.0133	CbGeAlD
Midazolam—GABRB3—female reproductive system—ovarian cancer	0.000792	0.0131	CbGeAlD
Midazolam—GABRE—testis—ovarian cancer	0.000754	0.0124	CbGeAlD
Midazolam—CYP3A5—uterine cervix—ovarian cancer	0.000721	0.0119	CbGeAlD
Midazolam—GABRB3—testis—ovarian cancer	0.000639	0.0105	CbGeAlD
Midazolam—CYP2B6—gonad—ovarian cancer	0.000601	0.00991	CbGeAlD
Midazolam—GABRA2—lymph node—ovarian cancer	0.000551	0.00909	CbGeAlD
Midazolam—GABRE—lymph node—ovarian cancer	0.000547	0.00901	CbGeAlD
Midazolam—CYP2B6—female reproductive system—ovarian cancer	0.000537	0.00885	CbGeAlD
Midazolam—CYP2E1—female reproductive system—ovarian cancer	0.000504	0.00831	CbGeAlD
Midazolam—ABCB1—myometrium—ovarian cancer	0.000492	0.00812	CbGeAlD
Midazolam—CYP3A5—female gonad—ovarian cancer	0.000492	0.00811	CbGeAlD
Midazolam—CYP3A5—vagina—ovarian cancer	0.000489	0.00806	CbGeAlD
Midazolam—CYP2B6—vagina—ovarian cancer	0.000486	0.00801	CbGeAlD
Midazolam—ABCB1—embryo—ovarian cancer	0.000473	0.00781	CbGeAlD
Midazolam—CYP2B6—testis—ovarian cancer	0.000433	0.00715	CbGeAlD
Midazolam—Bradycardia—Paclitaxel—ovarian cancer	0.000418	0.00191	CcSEcCtD
Midazolam—Feeling abnormal—Topotecan—ovarian cancer	0.000418	0.00191	CcSEcCtD
Midazolam—Skin exfoliation—Doxorubicin—ovarian cancer	0.000413	0.00189	CcSEcCtD
Midazolam—Asthenia—Chlorambucil—ovarian cancer	0.000409	0.00187	CcSEcCtD
Midazolam—CYP2E1—testis—ovarian cancer	0.000407	0.00671	CbGeAlD
Midazolam—CYP3A4—female reproductive system—ovarian cancer	0.000405	0.00669	CbGeAlD
Midazolam—Hypotension—Vinorelbine—ovarian cancer	0.000405	0.00186	CcSEcCtD
Midazolam—Connective tissue disorder—Paclitaxel—ovarian cancer	0.000404	0.00185	CcSEcCtD
Midazolam—Pruritus—Chlorambucil—ovarian cancer	0.000403	0.00185	CcSEcCtD
Midazolam—Urticaria—Topotecan—ovarian cancer	0.000403	0.00184	CcSEcCtD
Midazolam—Visual impairment—Paclitaxel—ovarian cancer	0.000396	0.00181	CcSEcCtD
Midazolam—Urticaria—Melphalan—ovarian cancer	0.000394	0.00181	CcSEcCtD
Midazolam—Phlebitis—Epirubicin—ovarian cancer	0.000394	0.0018	CcSEcCtD
Midazolam—Thrombophlebitis—Epirubicin—ovarian cancer	0.000392	0.0018	CcSEcCtD
Midazolam—Paraesthesia—Vinorelbine—ovarian cancer	0.000389	0.00178	CcSEcCtD
Midazolam—Dyspnoea—Vinorelbine—ovarian cancer	0.000387	0.00177	CcSEcCtD
Midazolam—ABCB1—epithelium—ovarian cancer	0.000386	0.00637	CbGeAlD
Midazolam—Eye disorder—Paclitaxel—ovarian cancer	0.000384	0.00176	CcSEcCtD
Midazolam—ABCB1—uterine cervix—ovarian cancer	0.000383	0.00632	CbGeAlD
Midazolam—Cardiac disorder—Paclitaxel—ovarian cancer	0.000381	0.00175	CcSEcCtD
Midazolam—Neuropathy peripheral—Docetaxel—ovarian cancer	0.00038	0.00174	CcSEcCtD
Midazolam—Gastrointestinal disorder—Vinorelbine—ovarian cancer	0.000374	0.00171	CcSEcCtD
Midazolam—Fatigue—Vinorelbine—ovarian cancer	0.000374	0.00171	CcSEcCtD
Midazolam—Hypersensitivity—Topotecan—ovarian cancer	0.000374	0.00171	CcSEcCtD
Midazolam—Pain—Vinorelbine—ovarian cancer	0.000371	0.0017	CcSEcCtD
Midazolam—Constipation—Vinorelbine—ovarian cancer	0.000371	0.0017	CcSEcCtD
Midazolam—Immune system disorder—Paclitaxel—ovarian cancer	0.000371	0.0017	CcSEcCtD
Midazolam—Mediastinal disorder—Paclitaxel—ovarian cancer	0.00037	0.00169	CcSEcCtD
Midazolam—Chills—Paclitaxel—ovarian cancer	0.000368	0.00169	CcSEcCtD
Midazolam—Hypersensitivity—Melphalan—ovarian cancer	0.000366	0.00167	CcSEcCtD
Midazolam—ABCB1—decidua—ovarian cancer	0.000365	0.00602	CbGeAlD
Midazolam—Phlebitis—Doxorubicin—ovarian cancer	0.000364	0.00167	CcSEcCtD
Midazolam—Asthenia—Topotecan—ovarian cancer	0.000364	0.00167	CcSEcCtD
Midazolam—Thrombophlebitis—Doxorubicin—ovarian cancer	0.000363	0.00166	CcSEcCtD
Midazolam—Vomiting—Chlorambucil—ovarian cancer	0.000362	0.00166	CcSEcCtD
Midazolam—Mental disorder—Paclitaxel—ovarian cancer	0.00036	0.00165	CcSEcCtD
Midazolam—Pruritus—Topotecan—ovarian cancer	0.000359	0.00164	CcSEcCtD
Midazolam—Erythema—Paclitaxel—ovarian cancer	0.000357	0.00164	CcSEcCtD
Midazolam—Feeling abnormal—Vinorelbine—ovarian cancer	0.000357	0.00164	CcSEcCtD
Midazolam—Asthenia—Melphalan—ovarian cancer	0.000356	0.00163	CcSEcCtD
Midazolam—Pruritus—Melphalan—ovarian cancer	0.000351	0.00161	CcSEcCtD
Midazolam—Tension—Paclitaxel—ovarian cancer	0.000351	0.00161	CcSEcCtD
Midazolam—Anaphylactoid reaction—Epirubicin—ovarian cancer	0.000351	0.00161	CcSEcCtD
Midazolam—Cardiac failure—Epirubicin—ovarian cancer	0.000348	0.00159	CcSEcCtD
Midazolam—Nervousness—Paclitaxel—ovarian cancer	0.000347	0.00159	CcSEcCtD
Midazolam—ABCB1—endometrium—ovarian cancer	0.000346	0.00571	CbGeAlD
Midazolam—Lethargy—Epirubicin—ovarian cancer	0.000346	0.00159	CcSEcCtD
Midazolam—Urticaria—Vinorelbine—ovarian cancer	0.000345	0.00158	CcSEcCtD
Midazolam—Connective tissue disorder—Docetaxel—ovarian cancer	0.000342	0.00157	CcSEcCtD
Midazolam—Osteoarthritis—Epirubicin—ovarian cancer	0.000339	0.00155	CcSEcCtD
Midazolam—Diplopia—Epirubicin—ovarian cancer	0.000339	0.00155	CcSEcCtD
Midazolam—Nausea—Chlorambucil—ovarian cancer	0.000338	0.00155	CcSEcCtD
Midazolam—Vision blurred—Paclitaxel—ovarian cancer	0.000337	0.00154	CcSEcCtD
Midazolam—Visual impairment—Docetaxel—ovarian cancer	0.000335	0.00154	CcSEcCtD
Midazolam—Dizziness—Topotecan—ovarian cancer	0.000335	0.00154	CcSEcCtD
Midazolam—Tremor—Paclitaxel—ovarian cancer	0.000335	0.00153	CcSEcCtD
Midazolam—Affect lability—Epirubicin—ovarian cancer	0.000334	0.00153	CcSEcCtD
Midazolam—Agitation—Paclitaxel—ovarian cancer	0.000328	0.0015	CcSEcCtD
Midazolam—Eye disorder—Docetaxel—ovarian cancer	0.000325	0.00149	CcSEcCtD
Midazolam—Anaphylactoid reaction—Doxorubicin—ovarian cancer	0.000324	0.00149	CcSEcCtD
Midazolam—Cardiac disorder—Docetaxel—ovarian cancer	0.000323	0.00148	CcSEcCtD
Midazolam—Cardiac arrest—Epirubicin—ovarian cancer	0.000323	0.00148	CcSEcCtD
Midazolam—Vomiting—Topotecan—ovarian cancer	0.000322	0.00148	CcSEcCtD
Midazolam—Cardiac failure—Doxorubicin—ovarian cancer	0.000322	0.00147	CcSEcCtD
Midazolam—Mood swings—Epirubicin—ovarian cancer	0.000321	0.00147	CcSEcCtD
Midazolam—ABCB1—gonad—ovarian cancer	0.000321	0.0053	CbGeAlD
Midazolam—Vertigo—Paclitaxel—ovarian cancer	0.000321	0.00147	CcSEcCtD
Midazolam—Syncope—Paclitaxel—ovarian cancer	0.000321	0.00147	CcSEcCtD
Midazolam—Lethargy—Doxorubicin—ovarian cancer	0.00032	0.00147	CcSEcCtD
Midazolam—Rash—Topotecan—ovarian cancer	0.00032	0.00146	CcSEcCtD
Midazolam—Hypersensitivity—Vinorelbine—ovarian cancer	0.00032	0.00146	CcSEcCtD
Midazolam—Dermatitis—Topotecan—ovarian cancer	0.000319	0.00146	CcSEcCtD
Midazolam—ABCB1—uterus—ovarian cancer	0.000319	0.00526	CbGeAlD
Midazolam—Ataxia—Epirubicin—ovarian cancer	0.000319	0.00146	CcSEcCtD
Midazolam—Headache—Topotecan—ovarian cancer	0.000318	0.00145	CcSEcCtD
Midazolam—Vomiting—Melphalan—ovarian cancer	0.000316	0.00145	CcSEcCtD
Midazolam—Immune system disorder—Docetaxel—ovarian cancer	0.000314	0.00144	CcSEcCtD
Midazolam—Osteoarthritis—Doxorubicin—ovarian cancer	0.000314	0.00144	CcSEcCtD
Midazolam—Diplopia—Doxorubicin—ovarian cancer	0.000314	0.00144	CcSEcCtD
Midazolam—Mediastinal disorder—Docetaxel—ovarian cancer	0.000314	0.00144	CcSEcCtD
Midazolam—Rash—Melphalan—ovarian cancer	0.000313	0.00143	CcSEcCtD
Midazolam—Dermatitis—Melphalan—ovarian cancer	0.000313	0.00143	CcSEcCtD
Midazolam—Chills—Docetaxel—ovarian cancer	0.000312	0.00143	CcSEcCtD
Midazolam—Cough—Paclitaxel—ovarian cancer	0.000312	0.00143	CcSEcCtD
Midazolam—Asthenia—Vinorelbine—ovarian cancer	0.000311	0.00142	CcSEcCtD
Midazolam—Affect lability—Doxorubicin—ovarian cancer	0.000309	0.00142	CcSEcCtD
Midazolam—Pruritus—Vinorelbine—ovarian cancer	0.000307	0.00141	CcSEcCtD
Midazolam—Mental disorder—Docetaxel—ovarian cancer	0.000305	0.0014	CcSEcCtD
Midazolam—Nasopharyngitis—Epirubicin—ovarian cancer	0.000303	0.00139	CcSEcCtD
Midazolam—Anxiety—Paclitaxel—ovarian cancer	0.000303	0.00139	CcSEcCtD
Midazolam—Erythema—Docetaxel—ovarian cancer	0.000303	0.00139	CcSEcCtD
Midazolam—Unspecified disorder of skin and subcutaneous tissue—Paclitaxel—ovarian cancer	0.000302	0.00138	CcSEcCtD
Midazolam—Nausea—Topotecan—ovarian cancer	0.000301	0.00138	CcSEcCtD
Midazolam—Muscular weakness—Epirubicin—ovarian cancer	0.000299	0.00137	CcSEcCtD
Midazolam—Cardiac arrest—Doxorubicin—ovarian cancer	0.000299	0.00137	CcSEcCtD
Midazolam—Dry mouth—Paclitaxel—ovarian cancer	0.000298	0.00136	CcSEcCtD
Midazolam—Mood swings—Doxorubicin—ovarian cancer	0.000297	0.00136	CcSEcCtD
Midazolam—Ataxia—Doxorubicin—ovarian cancer	0.000295	0.00135	CcSEcCtD
Midazolam—Nausea—Melphalan—ovarian cancer	0.000295	0.00135	CcSEcCtD
Midazolam—Confusional state—Paclitaxel—ovarian cancer	0.000294	0.00135	CcSEcCtD
Midazolam—Anaphylactic shock—Paclitaxel—ovarian cancer	0.000292	0.00134	CcSEcCtD
Midazolam—Shock—Paclitaxel—ovarian cancer	0.000287	0.00131	CcSEcCtD
Midazolam—ABCB1—female reproductive system—ovarian cancer	0.000287	0.00473	CbGeAlD
Midazolam—Dizziness—Vinorelbine—ovarian cancer	0.000287	0.00131	CcSEcCtD
Midazolam—Nervous system disorder—Paclitaxel—ovarian cancer	0.000286	0.00131	CcSEcCtD
Midazolam—Tachycardia—Paclitaxel—ovarian cancer	0.000285	0.0013	CcSEcCtD
Midazolam—Skin disorder—Paclitaxel—ovarian cancer	0.000283	0.0013	CcSEcCtD
Midazolam—Nasopharyngitis—Doxorubicin—ovarian cancer	0.000281	0.00129	CcSEcCtD
Midazolam—Muscular weakness—Doxorubicin—ovarian cancer	0.000277	0.00127	CcSEcCtD
Midazolam—Vomiting—Vinorelbine—ovarian cancer	0.000276	0.00126	CcSEcCtD
Midazolam—Rash—Vinorelbine—ovarian cancer	0.000273	0.00125	CcSEcCtD
Midazolam—Dermatitis—Vinorelbine—ovarian cancer	0.000273	0.00125	CcSEcCtD
Midazolam—Hypotension—Paclitaxel—ovarian cancer	0.000273	0.00125	CcSEcCtD
Midazolam—Headache—Vinorelbine—ovarian cancer	0.000272	0.00124	CcSEcCtD
Midazolam—Syncope—Docetaxel—ovarian cancer	0.000272	0.00124	CcSEcCtD
Midazolam—ABCB1—bone marrow—ovarian cancer	0.000271	0.00447	CbGeAlD
Midazolam—Cough—Docetaxel—ovarian cancer	0.000264	0.00121	CcSEcCtD
Midazolam—Paraesthesia—Paclitaxel—ovarian cancer	0.000262	0.0012	CcSEcCtD
Midazolam—Drowsiness—Epirubicin—ovarian cancer	0.000261	0.0012	CcSEcCtD
Midazolam—ABCB1—female gonad—ovarian cancer	0.000261	0.00431	CbGeAlD
Midazolam—Dyspnoea—Paclitaxel—ovarian cancer	0.00026	0.00119	CcSEcCtD
Midazolam—ABCB1—vagina—ovarian cancer	0.00026	0.00428	CbGeAlD
Midazolam—Somnolence—Paclitaxel—ovarian cancer	0.000259	0.00119	CcSEcCtD
Midazolam—Nausea—Vinorelbine—ovarian cancer	0.000258	0.00118	CcSEcCtD
Midazolam—Dyspepsia—Paclitaxel—ovarian cancer	0.000257	0.00118	CcSEcCtD
Midazolam—Neuropathy peripheral—Epirubicin—ovarian cancer	0.000256	0.00117	CcSEcCtD
Midazolam—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—ovarian cancer	0.000256	0.00117	CcSEcCtD
Midazolam—Dry mouth—Docetaxel—ovarian cancer	0.000252	0.00116	CcSEcCtD
Midazolam—Gastrointestinal disorder—Paclitaxel—ovarian cancer	0.000252	0.00115	CcSEcCtD
Midazolam—Fatigue—Paclitaxel—ovarian cancer	0.000252	0.00115	CcSEcCtD
Midazolam—Pain—Paclitaxel—ovarian cancer	0.000249	0.00114	CcSEcCtD
Midazolam—Constipation—Paclitaxel—ovarian cancer	0.000249	0.00114	CcSEcCtD
Midazolam—Confusional state—Docetaxel—ovarian cancer	0.000249	0.00114	CcSEcCtD
Midazolam—Anaphylactic shock—Docetaxel—ovarian cancer	0.000247	0.00113	CcSEcCtD
Midazolam—Shock—Docetaxel—ovarian cancer	0.000243	0.00111	CcSEcCtD
Midazolam—Nervous system disorder—Docetaxel—ovarian cancer	0.000242	0.00111	CcSEcCtD
Midazolam—Drowsiness—Doxorubicin—ovarian cancer	0.000242	0.00111	CcSEcCtD
Midazolam—Tachycardia—Docetaxel—ovarian cancer	0.000241	0.00111	CcSEcCtD
Midazolam—Feeling abnormal—Paclitaxel—ovarian cancer	0.00024	0.0011	CcSEcCtD
Midazolam—Skin disorder—Docetaxel—ovarian cancer	0.00024	0.0011	CcSEcCtD
Midazolam—Bradycardia—Epirubicin—ovarian cancer	0.000239	0.00109	CcSEcCtD
Midazolam—Neuropathy peripheral—Doxorubicin—ovarian cancer	0.000237	0.00109	CcSEcCtD
Midazolam—Urticaria—Paclitaxel—ovarian cancer	0.000232	0.00106	CcSEcCtD
Midazolam—ABCB1—testis—ovarian cancer	0.000232	0.00382	CbGeAlD
Midazolam—Hypotension—Docetaxel—ovarian cancer	0.000231	0.00106	CcSEcCtD
Midazolam—Connective tissue disorder—Epirubicin—ovarian cancer	0.000231	0.00106	CcSEcCtD
Midazolam—Visual impairment—Epirubicin—ovarian cancer	0.000226	0.00104	CcSEcCtD
Midazolam—Paraesthesia—Docetaxel—ovarian cancer	0.000222	0.00102	CcSEcCtD
Midazolam—Bradycardia—Doxorubicin—ovarian cancer	0.000221	0.00101	CcSEcCtD
Midazolam—Dyspnoea—Docetaxel—ovarian cancer	0.00022	0.00101	CcSEcCtD
Midazolam—Somnolence—Docetaxel—ovarian cancer	0.00022	0.00101	CcSEcCtD
Midazolam—Eye disorder—Epirubicin—ovarian cancer	0.000219	0.001	CcSEcCtD
Midazolam—Cardiac disorder—Epirubicin—ovarian cancer	0.000218	0.000998	CcSEcCtD
Midazolam—Dyspepsia—Docetaxel—ovarian cancer	0.000218	0.000997	CcSEcCtD
Midazolam—Hypersensitivity—Paclitaxel—ovarian cancer	0.000215	0.000984	CcSEcCtD
Midazolam—Gastrointestinal disorder—Docetaxel—ovarian cancer	0.000213	0.000978	CcSEcCtD
Midazolam—Connective tissue disorder—Doxorubicin—ovarian cancer	0.000213	0.000977	CcSEcCtD
Midazolam—Fatigue—Docetaxel—ovarian cancer	0.000213	0.000976	CcSEcCtD
Midazolam—Immune system disorder—Epirubicin—ovarian cancer	0.000212	0.000971	CcSEcCtD
Midazolam—Mediastinal disorder—Epirubicin—ovarian cancer	0.000212	0.000969	CcSEcCtD
Midazolam—Pain—Docetaxel—ovarian cancer	0.000211	0.000968	CcSEcCtD
Midazolam—Constipation—Docetaxel—ovarian cancer	0.000211	0.000968	CcSEcCtD
Midazolam—Chills—Epirubicin—ovarian cancer	0.000211	0.000965	CcSEcCtD
Midazolam—Visual impairment—Doxorubicin—ovarian cancer	0.000209	0.000959	CcSEcCtD
Midazolam—Asthenia—Paclitaxel—ovarian cancer	0.000209	0.000958	CcSEcCtD
Midazolam—Pruritus—Paclitaxel—ovarian cancer	0.000206	0.000945	CcSEcCtD
Midazolam—Mental disorder—Epirubicin—ovarian cancer	0.000206	0.000942	CcSEcCtD
Midazolam—Erythema—Epirubicin—ovarian cancer	0.000204	0.000936	CcSEcCtD
Midazolam—Feeling abnormal—Docetaxel—ovarian cancer	0.000204	0.000933	CcSEcCtD
Midazolam—Eye disorder—Doxorubicin—ovarian cancer	0.000203	0.00093	CcSEcCtD
Midazolam—Cardiac disorder—Doxorubicin—ovarian cancer	0.000202	0.000923	CcSEcCtD
Midazolam—Tension—Epirubicin—ovarian cancer	0.000201	0.000918	CcSEcCtD
Midazolam—Nervousness—Epirubicin—ovarian cancer	0.000198	0.000909	CcSEcCtD
Midazolam—Immune system disorder—Doxorubicin—ovarian cancer	0.000196	0.000898	CcSEcCtD
Midazolam—Mediastinal disorder—Doxorubicin—ovarian cancer	0.000196	0.000896	CcSEcCtD
Midazolam—Chills—Doxorubicin—ovarian cancer	0.000195	0.000892	CcSEcCtD
Midazolam—Dizziness—Paclitaxel—ovarian cancer	0.000193	0.000883	CcSEcCtD
Midazolam—Vision blurred—Epirubicin—ovarian cancer	0.000193	0.000882	CcSEcCtD
Midazolam—Mental disorder—Doxorubicin—ovarian cancer	0.00019	0.000871	CcSEcCtD
Midazolam—Erythema—Doxorubicin—ovarian cancer	0.000189	0.000866	CcSEcCtD
Midazolam—Agitation—Epirubicin—ovarian cancer	0.000188	0.00086	CcSEcCtD
Midazolam—Tension—Doxorubicin—ovarian cancer	0.000186	0.00085	CcSEcCtD
Midazolam—Vomiting—Paclitaxel—ovarian cancer	0.000185	0.000849	CcSEcCtD
Midazolam—Rash—Paclitaxel—ovarian cancer	0.000184	0.000842	CcSEcCtD
Midazolam—Dermatitis—Paclitaxel—ovarian cancer	0.000184	0.000841	CcSEcCtD
Midazolam—Nervousness—Doxorubicin—ovarian cancer	0.000184	0.000841	CcSEcCtD
Midazolam—Vertigo—Epirubicin—ovarian cancer	0.000184	0.000841	CcSEcCtD
Midazolam—Syncope—Epirubicin—ovarian cancer	0.000183	0.000839	CcSEcCtD
Midazolam—Headache—Paclitaxel—ovarian cancer	0.000183	0.000837	CcSEcCtD
Midazolam—Hypersensitivity—Docetaxel—ovarian cancer	0.000182	0.000834	CcSEcCtD
Midazolam—Cough—Epirubicin—ovarian cancer	0.000178	0.000817	CcSEcCtD
Midazolam—Vision blurred—Doxorubicin—ovarian cancer	0.000178	0.000816	CcSEcCtD
Midazolam—Asthenia—Docetaxel—ovarian cancer	0.000177	0.000812	CcSEcCtD
Midazolam—Pruritus—Docetaxel—ovarian cancer	0.000175	0.000801	CcSEcCtD
Midazolam—Agitation—Doxorubicin—ovarian cancer	0.000174	0.000796	CcSEcCtD
Midazolam—Anxiety—Epirubicin—ovarian cancer	0.000173	0.000794	CcSEcCtD
Midazolam—Nausea—Paclitaxel—ovarian cancer	0.000173	0.000793	CcSEcCtD
Midazolam—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—ovarian cancer	0.000173	0.000791	CcSEcCtD
Midazolam—Dry mouth—Epirubicin—ovarian cancer	0.00017	0.000779	CcSEcCtD
Midazolam—Vertigo—Doxorubicin—ovarian cancer	0.00017	0.000778	CcSEcCtD
Midazolam—Syncope—Doxorubicin—ovarian cancer	0.00017	0.000776	CcSEcCtD
Midazolam—Confusional state—Epirubicin—ovarian cancer	0.000168	0.00077	CcSEcCtD
Midazolam—ABCB1—lymph node—ovarian cancer	0.000168	0.00277	CbGeAlD
Midazolam—Anaphylactic shock—Epirubicin—ovarian cancer	0.000167	0.000764	CcSEcCtD
Midazolam—Cough—Doxorubicin—ovarian cancer	0.000165	0.000756	CcSEcCtD
Midazolam—Shock—Epirubicin—ovarian cancer	0.000164	0.000751	CcSEcCtD
Midazolam—Nervous system disorder—Epirubicin—ovarian cancer	0.000164	0.000749	CcSEcCtD
Midazolam—Dizziness—Docetaxel—ovarian cancer	0.000164	0.000749	CcSEcCtD
Midazolam—Tachycardia—Epirubicin—ovarian cancer	0.000163	0.000745	CcSEcCtD
Midazolam—Skin disorder—Epirubicin—ovarian cancer	0.000162	0.000742	CcSEcCtD
Midazolam—Anxiety—Doxorubicin—ovarian cancer	0.00016	0.000735	CcSEcCtD
Midazolam—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—ovarian cancer	0.00016	0.000732	CcSEcCtD
Midazolam—Dry mouth—Doxorubicin—ovarian cancer	0.000157	0.000721	CcSEcCtD
Midazolam—Vomiting—Docetaxel—ovarian cancer	0.000157	0.00072	CcSEcCtD
Midazolam—Rash—Docetaxel—ovarian cancer	0.000156	0.000714	CcSEcCtD
Midazolam—Hypotension—Epirubicin—ovarian cancer	0.000156	0.000714	CcSEcCtD
Midazolam—Dermatitis—Docetaxel—ovarian cancer	0.000156	0.000713	CcSEcCtD
Midazolam—Confusional state—Doxorubicin—ovarian cancer	0.000156	0.000713	CcSEcCtD
Midazolam—Headache—Docetaxel—ovarian cancer	0.000155	0.000709	CcSEcCtD
Midazolam—Anaphylactic shock—Doxorubicin—ovarian cancer	0.000154	0.000707	CcSEcCtD
Midazolam—Shock—Doxorubicin—ovarian cancer	0.000152	0.000695	CcSEcCtD
Midazolam—Nervous system disorder—Doxorubicin—ovarian cancer	0.000151	0.000693	CcSEcCtD
Midazolam—Tachycardia—Doxorubicin—ovarian cancer	0.000151	0.00069	CcSEcCtD
Midazolam—Skin disorder—Doxorubicin—ovarian cancer	0.00015	0.000686	CcSEcCtD
Midazolam—Paraesthesia—Epirubicin—ovarian cancer	0.00015	0.000686	CcSEcCtD
Midazolam—Dyspnoea—Epirubicin—ovarian cancer	0.000149	0.000681	CcSEcCtD
Midazolam—Somnolence—Epirubicin—ovarian cancer	0.000148	0.000679	CcSEcCtD
Midazolam—Nausea—Docetaxel—ovarian cancer	0.000147	0.000673	CcSEcCtD
Midazolam—Dyspepsia—Epirubicin—ovarian cancer	0.000147	0.000672	CcSEcCtD
Midazolam—Hypotension—Doxorubicin—ovarian cancer	0.000144	0.00066	CcSEcCtD
Midazolam—Gastrointestinal disorder—Epirubicin—ovarian cancer	0.000144	0.000659	CcSEcCtD
Midazolam—Fatigue—Epirubicin—ovarian cancer	0.000144	0.000658	CcSEcCtD
Midazolam—Pain—Epirubicin—ovarian cancer	0.000143	0.000653	CcSEcCtD
Midazolam—Constipation—Epirubicin—ovarian cancer	0.000143	0.000653	CcSEcCtD
Midazolam—Paraesthesia—Doxorubicin—ovarian cancer	0.000139	0.000635	CcSEcCtD
Midazolam—Dyspnoea—Doxorubicin—ovarian cancer	0.000138	0.00063	CcSEcCtD
Midazolam—Feeling abnormal—Epirubicin—ovarian cancer	0.000137	0.000629	CcSEcCtD
Midazolam—Somnolence—Doxorubicin—ovarian cancer	0.000137	0.000628	CcSEcCtD
Midazolam—Dyspepsia—Doxorubicin—ovarian cancer	0.000136	0.000622	CcSEcCtD
Midazolam—Gastrointestinal disorder—Doxorubicin—ovarian cancer	0.000133	0.00061	CcSEcCtD
Midazolam—Fatigue—Doxorubicin—ovarian cancer	0.000133	0.000609	CcSEcCtD
Midazolam—Urticaria—Epirubicin—ovarian cancer	0.000132	0.000607	CcSEcCtD
Midazolam—Constipation—Doxorubicin—ovarian cancer	0.000132	0.000604	CcSEcCtD
Midazolam—Pain—Doxorubicin—ovarian cancer	0.000132	0.000604	CcSEcCtD
Midazolam—Feeling abnormal—Doxorubicin—ovarian cancer	0.000127	0.000582	CcSEcCtD
Midazolam—Hypersensitivity—Epirubicin—ovarian cancer	0.000123	0.000563	CcSEcCtD
Midazolam—Urticaria—Doxorubicin—ovarian cancer	0.000123	0.000561	CcSEcCtD
Midazolam—Asthenia—Epirubicin—ovarian cancer	0.00012	0.000548	CcSEcCtD
Midazolam—Pruritus—Epirubicin—ovarian cancer	0.000118	0.00054	CcSEcCtD
Midazolam—Hypersensitivity—Doxorubicin—ovarian cancer	0.000114	0.000521	CcSEcCtD
Midazolam—Asthenia—Doxorubicin—ovarian cancer	0.000111	0.000507	CcSEcCtD
Midazolam—Dizziness—Epirubicin—ovarian cancer	0.00011	0.000505	CcSEcCtD
Midazolam—Pruritus—Doxorubicin—ovarian cancer	0.000109	0.0005	CcSEcCtD
Midazolam—Vomiting—Epirubicin—ovarian cancer	0.000106	0.000486	CcSEcCtD
Midazolam—Rash—Epirubicin—ovarian cancer	0.000105	0.000482	CcSEcCtD
Midazolam—Dermatitis—Epirubicin—ovarian cancer	0.000105	0.000481	CcSEcCtD
Midazolam—Headache—Epirubicin—ovarian cancer	0.000104	0.000478	CcSEcCtD
Midazolam—Dizziness—Doxorubicin—ovarian cancer	0.000102	0.000467	CcSEcCtD
Midazolam—Nausea—Epirubicin—ovarian cancer	9.91e-05	0.000454	CcSEcCtD
Midazolam—Vomiting—Doxorubicin—ovarian cancer	9.81e-05	0.000449	CcSEcCtD
Midazolam—Rash—Doxorubicin—ovarian cancer	9.73e-05	0.000446	CcSEcCtD
Midazolam—Dermatitis—Doxorubicin—ovarian cancer	9.72e-05	0.000445	CcSEcCtD
Midazolam—Headache—Doxorubicin—ovarian cancer	9.67e-05	0.000443	CcSEcCtD
Midazolam—Nausea—Doxorubicin—ovarian cancer	9.17e-05	0.00042	CcSEcCtD
Midazolam—ABCB1—Allograft Rejection—CASP3—ovarian cancer	3.38e-05	0.000709	CbGpPWpGaD
Midazolam—ABCB1—Allograft Rejection—IL2—ovarian cancer	3.37e-05	0.000708	CbGpPWpGaD
Midazolam—GABRA4—Transmission across Chemical Synapses—MAPK1—ovarian cancer	3.34e-05	0.000703	CbGpPWpGaD
Midazolam—GABRA1—SIDS Susceptibility Pathways—VEGFA—ovarian cancer	3.31e-05	0.000696	CbGpPWpGaD
Midazolam—ABCB1—HIF-1-alpha transcription factor network—VEGFA—ovarian cancer	3.31e-05	0.000695	CbGpPWpGaD
Midazolam—GABRA1—Transmembrane transport of small molecules—SLC2A1—ovarian cancer	3.29e-05	0.000691	CbGpPWpGaD
Midazolam—ABCB1—Integrated Pancreatic Cancer Pathway—CCNE1—ovarian cancer	3.28e-05	0.000689	CbGpPWpGaD
Midazolam—GABRB2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—HRAS—ovarian cancer	3.27e-05	0.000686	CbGpPWpGaD
Midazolam—GABRA1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—MAPK1—ovarian cancer	3.25e-05	0.000683	CbGpPWpGaD
Midazolam—GABRB2—Transmembrane transport of small molecules—ABCB1—ovarian cancer	3.25e-05	0.000682	CbGpPWpGaD
Midazolam—ABCB1—Transmembrane transport of small molecules—ATP7B—ovarian cancer	3.24e-05	0.00068	CbGpPWpGaD
Midazolam—ABCB1—Integrated Pancreatic Cancer Pathway—TYMS—ovarian cancer	3.22e-05	0.000677	CbGpPWpGaD
Midazolam—GABRA5—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—HRAS—ovarian cancer	3.17e-05	0.000667	CbGpPWpGaD
Midazolam—GABRA5—Transmembrane transport of small molecules—ABCB1—ovarian cancer	3.15e-05	0.000663	CbGpPWpGaD
Midazolam—CYP3A7—Metabolism—CYTB—ovarian cancer	3.12e-05	0.000655	CbGpPWpGaD
Midazolam—GABRA3—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—HRAS—ovarian cancer	3.12e-05	0.000655	CbGpPWpGaD
Midazolam—GABRA3—Transmembrane transport of small molecules—ABCB1—ovarian cancer	3.1e-05	0.000651	CbGpPWpGaD
Midazolam—UGT1A4—Metabolism—FASN—ovarian cancer	3.09e-05	0.000648	CbGpPWpGaD
Midazolam—GABRA2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—HRAS—ovarian cancer	3.06e-05	0.000643	CbGpPWpGaD
Midazolam—GABRB2—Transmission across Chemical Synapses—MAPK1—ovarian cancer	3.06e-05	0.000643	CbGpPWpGaD
Midazolam—GABRA2—Transmembrane transport of small molecules—ABCB1—ovarian cancer	3.04e-05	0.00064	CbGpPWpGaD
Midazolam—GABRB3—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—HRAS—ovarian cancer	3.04e-05	0.000639	CbGpPWpGaD
Midazolam—UGT1A4—Metabolism—SLC5A5—ovarian cancer	3.04e-05	0.000638	CbGpPWpGaD
Midazolam—GABRB3—Transmembrane transport of small molecules—ABCB1—ovarian cancer	3.02e-05	0.000635	CbGpPWpGaD
Midazolam—GABRG2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—HRAS—ovarian cancer	2.99e-05	0.000628	CbGpPWpGaD
Midazolam—GABRB3—BDNF signaling pathway—HRAS—ovarian cancer	2.97e-05	0.000625	CbGpPWpGaD
Midazolam—GABRA5—Transmission across Chemical Synapses—MAPK1—ovarian cancer	2.97e-05	0.000624	CbGpPWpGaD
Midazolam—GABRG2—Transmembrane transport of small molecules—ABCB1—ovarian cancer	2.97e-05	0.000624	CbGpPWpGaD
Midazolam—UGT1A4—Metabolism—SLC2A1—ovarian cancer	2.93e-05	0.000616	CbGpPWpGaD
Midazolam—CYP4B1—Metabolism—CAV1—ovarian cancer	2.93e-05	0.000615	CbGpPWpGaD
Midazolam—GABRA3—Transmission across Chemical Synapses—MAPK1—ovarian cancer	2.92e-05	0.000613	CbGpPWpGaD
Midazolam—GABRG3—Transmission across Chemical Synapses—HRAS—ovarian cancer	2.92e-05	0.000613	CbGpPWpGaD
Midazolam—SLC22A1—Transmembrane transport of small molecules—SLC5A5—ovarian cancer	2.91e-05	0.000612	CbGpPWpGaD
Midazolam—SLC22A1—Metabolism—CYTB—ovarian cancer	2.9e-05	0.00061	CbGpPWpGaD
Midazolam—GABRB1—Transmission across Chemical Synapses—HRAS—ovarian cancer	2.87e-05	0.000604	CbGpPWpGaD
Midazolam—GABRA2—Transmission across Chemical Synapses—MAPK1—ovarian cancer	2.87e-05	0.000603	CbGpPWpGaD
Midazolam—ABCB1—Allograft Rejection—VEGFA—ovarian cancer	2.86e-05	0.000602	CbGpPWpGaD
Midazolam—GABRB3—Transmission across Chemical Synapses—MAPK1—ovarian cancer	2.85e-05	0.000599	CbGpPWpGaD
Midazolam—GABRR1—Neuronal System—HRAS—ovarian cancer	2.84e-05	0.000598	CbGpPWpGaD
Midazolam—SLC22A1—Transmembrane transport of small molecules—SLC2A1—ovarian cancer	2.81e-05	0.000591	CbGpPWpGaD
Midazolam—UGT1A4—Metabolism—CYP1B1—ovarian cancer	2.81e-05	0.000591	CbGpPWpGaD
Midazolam—GABRG2—Transmission across Chemical Synapses—MAPK1—ovarian cancer	2.8e-05	0.000588	CbGpPWpGaD
Midazolam—CYP4B1—Metabolism of lipids and lipoproteins—PIK3CA—ovarian cancer	2.8e-05	0.000588	CbGpPWpGaD
Midazolam—GABRG3—Neuronal System—MAPK1—ovarian cancer	2.78e-05	0.000585	CbGpPWpGaD
Midazolam—GABRB1—Neuronal System—MAPK1—ovarian cancer	2.74e-05	0.000576	CbGpPWpGaD
Midazolam—CYP3A7—Metabolism—BRIP1—ovarian cancer	2.73e-05	0.000573	CbGpPWpGaD
Midazolam—CYP3A7—Metabolism—PPP1CC—ovarian cancer	2.73e-05	0.000573	CbGpPWpGaD
Midazolam—GABRA6—Transmission across Chemical Synapses—HRAS—ovarian cancer	2.72e-05	0.000571	CbGpPWpGaD
Midazolam—GABRR2—Neuronal System—HRAS—ovarian cancer	2.71e-05	0.00057	CbGpPWpGaD
Midazolam—GABRQ—Neuronal System—HRAS—ovarian cancer	2.71e-05	0.00057	CbGpPWpGaD
Midazolam—GABRA4—Transmission across Chemical Synapses—HRAS—ovarian cancer	2.68e-05	0.000564	CbGpPWpGaD
Midazolam—CYP3A4—Biological oxidations—CYP1B1—ovarian cancer	2.67e-05	0.000561	CbGpPWpGaD
Midazolam—CYP4B1—Metabolism—PIK3CG—ovarian cancer	2.67e-05	0.00056	CbGpPWpGaD
Midazolam—ABCB1—Metabolism—NME2—ovarian cancer	2.64e-05	0.000555	CbGpPWpGaD
Midazolam—CYP3A4—Metapathway biotransformation—CYP1B1—ovarian cancer	2.63e-05	0.000553	CbGpPWpGaD
Midazolam—GABRB3—BDNF signaling pathway—AKT1—ovarian cancer	2.63e-05	0.000552	CbGpPWpGaD
Midazolam—GABRA1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—HRAS—ovarian cancer	2.61e-05	0.000549	CbGpPWpGaD
Midazolam—GABRA1—Transmembrane transport of small molecules—ABCB1—ovarian cancer	2.6e-05	0.000545	CbGpPWpGaD
Midazolam—GABRA6—Neuronal System—MAPK1—ovarian cancer	2.59e-05	0.000545	CbGpPWpGaD
Midazolam—GABRA4—Neuronal System—MAPK1—ovarian cancer	2.56e-05	0.000538	CbGpPWpGaD
Midazolam—ABCB1—Transmembrane transport of small molecules—TUBB3—ovarian cancer	2.56e-05	0.000538	CbGpPWpGaD
Midazolam—SLC22A1—Metabolism—PPP1CC—ovarian cancer	2.54e-05	0.000533	CbGpPWpGaD
Midazolam—SLC22A1—Metabolism—BRIP1—ovarian cancer	2.54e-05	0.000533	CbGpPWpGaD
Midazolam—ABCB1—Integrated Pancreatic Cancer Pathway—ESR1—ovarian cancer	2.5e-05	0.000525	CbGpPWpGaD
Midazolam—UGT1A4—Metabolism—PPP2R1A—ovarian cancer	2.49e-05	0.000524	CbGpPWpGaD
Midazolam—GABRB2—Transmission across Chemical Synapses—HRAS—ovarian cancer	2.46e-05	0.000516	CbGpPWpGaD
Midazolam—GABRA1—Transmission across Chemical Synapses—MAPK1—ovarian cancer	2.44e-05	0.000514	CbGpPWpGaD
Midazolam—GABRA5—Transmission across Chemical Synapses—HRAS—ovarian cancer	2.39e-05	0.000501	CbGpPWpGaD
Midazolam—ABCB1—Integrated Pancreatic Cancer Pathway—APC—ovarian cancer	2.36e-05	0.000497	CbGpPWpGaD
Midazolam—CYP4B1—Metabolism—PIK3CD—ovarian cancer	2.34e-05	0.000493	CbGpPWpGaD
Midazolam—GABRB2—Neuronal System—MAPK1—ovarian cancer	2.34e-05	0.000492	CbGpPWpGaD
Midazolam—GABRA3—Transmission across Chemical Synapses—HRAS—ovarian cancer	2.34e-05	0.000492	CbGpPWpGaD
Midazolam—UGT1A4—Metabolism—ABCB1—ovarian cancer	2.31e-05	0.000486	CbGpPWpGaD
Midazolam—CYP2B6—Metabolism—CYTB—ovarian cancer	2.31e-05	0.000485	CbGpPWpGaD
Midazolam—GABRA2—Transmission across Chemical Synapses—HRAS—ovarian cancer	2.3e-05	0.000484	CbGpPWpGaD
Midazolam—GABRA1—SIDS Susceptibility Pathways—IL6—ovarian cancer	2.29e-05	0.000482	CbGpPWpGaD
Midazolam—GABRB3—Transmission across Chemical Synapses—HRAS—ovarian cancer	2.29e-05	0.000481	CbGpPWpGaD
Midazolam—GABRA5—Neuronal System—MAPK1—ovarian cancer	2.28e-05	0.000478	CbGpPWpGaD
Midazolam—UGT1A4—Metabolism—TYMS—ovarian cancer	2.27e-05	0.000478	CbGpPWpGaD
Midazolam—CYP2E1—Metabolism—CYTB—ovarian cancer	2.26e-05	0.000475	CbGpPWpGaD
Midazolam—CYP3A5—Metabolism—CYTB—ovarian cancer	2.25e-05	0.000474	CbGpPWpGaD
Midazolam—GABRG2—Transmission across Chemical Synapses—HRAS—ovarian cancer	2.25e-05	0.000472	CbGpPWpGaD
Midazolam—GABRA3—Neuronal System—MAPK1—ovarian cancer	2.24e-05	0.00047	CbGpPWpGaD
Midazolam—GABRG3—Neuronal System—HRAS—ovarian cancer	2.23e-05	0.00047	CbGpPWpGaD
Midazolam—SLC22A1—Transmembrane transport of small molecules—ABCB1—ovarian cancer	2.22e-05	0.000467	CbGpPWpGaD
Midazolam—GABRB1—Neuronal System—HRAS—ovarian cancer	2.2e-05	0.000463	CbGpPWpGaD
Midazolam—GABRA2—Neuronal System—MAPK1—ovarian cancer	2.2e-05	0.000462	CbGpPWpGaD
Midazolam—GABRB3—Neuronal System—MAPK1—ovarian cancer	2.18e-05	0.000459	CbGpPWpGaD
Midazolam—GABRG2—Neuronal System—MAPK1—ovarian cancer	2.14e-05	0.00045	CbGpPWpGaD
Midazolam—ABCB1—HIF-1-alpha transcription factor network—AKT1—ovarian cancer	2.11e-05	0.000443	CbGpPWpGaD
Midazolam—SLC22A1—Transmission across Chemical Synapses—MAPK1—ovarian cancer	2.09e-05	0.00044	CbGpPWpGaD
Midazolam—GABRA6—Neuronal System—HRAS—ovarian cancer	2.08e-05	0.000438	CbGpPWpGaD
Midazolam—GABRA4—Neuronal System—HRAS—ovarian cancer	2.06e-05	0.000432	CbGpPWpGaD
Midazolam—CYP4B1—Metabolism—PIK3CB—ovarian cancer	2.04e-05	0.000429	CbGpPWpGaD
Midazolam—CYP2B6—Metabolism—PPP1CC—ovarian cancer	2.02e-05	0.000424	CbGpPWpGaD
Midazolam—CYP2B6—Metabolism—BRIP1—ovarian cancer	2.02e-05	0.000424	CbGpPWpGaD
Midazolam—CYP2E1—Metabolism—PPP1CC—ovarian cancer	1.97e-05	0.000415	CbGpPWpGaD
Midazolam—CYP2E1—Metabolism—BRIP1—ovarian cancer	1.97e-05	0.000415	CbGpPWpGaD
Midazolam—CYP3A5—Metabolism—PPP1CC—ovarian cancer	1.97e-05	0.000414	CbGpPWpGaD
Midazolam—CYP3A5—Metabolism—BRIP1—ovarian cancer	1.97e-05	0.000414	CbGpPWpGaD
Midazolam—GABRA1—Transmission across Chemical Synapses—HRAS—ovarian cancer	1.96e-05	0.000412	CbGpPWpGaD
Midazolam—GABRB2—Neuronal System—HRAS—ovarian cancer	1.88e-05	0.000395	CbGpPWpGaD
Midazolam—GABRA1—Neuronal System—MAPK1—ovarian cancer	1.87e-05	0.000394	CbGpPWpGaD
Midazolam—ABCB1—Integrated Pancreatic Cancer Pathway—ERBB2—ovarian cancer	1.84e-05	0.000386	CbGpPWpGaD
Midazolam—UGT1A4—Metabolism—CAV1—ovarian cancer	1.83e-05	0.000385	CbGpPWpGaD
Midazolam—CYP3A7—Metabolism—YAP1—ovarian cancer	1.83e-05	0.000384	CbGpPWpGaD
Midazolam—GABRA5—Neuronal System—HRAS—ovarian cancer	1.83e-05	0.000384	CbGpPWpGaD
Midazolam—GABRA3—Neuronal System—HRAS—ovarian cancer	1.79e-05	0.000377	CbGpPWpGaD
Midazolam—CYP4B1—Metabolism—PTEN—ovarian cancer	1.77e-05	0.000371	CbGpPWpGaD
Midazolam—GABRA2—Neuronal System—HRAS—ovarian cancer	1.76e-05	0.000371	CbGpPWpGaD
Midazolam—GABRB3—Neuronal System—HRAS—ovarian cancer	1.75e-05	0.000368	CbGpPWpGaD
Midazolam—GABRG2—Neuronal System—HRAS—ovarian cancer	1.72e-05	0.000362	CbGpPWpGaD
Midazolam—ABCB1—Transmembrane transport of small molecules—SLC5A5—ovarian cancer	1.71e-05	0.000359	CbGpPWpGaD
Midazolam—SLC22A1—Metabolism—YAP1—ovarian cancer	1.7e-05	0.000358	CbGpPWpGaD
Midazolam—ABCB1—Metabolism—CYTB—ovarian cancer	1.7e-05	0.000357	CbGpPWpGaD
Midazolam—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN1B—ovarian cancer	1.7e-05	0.000357	CbGpPWpGaD
Midazolam—SLC22A1—Transmission across Chemical Synapses—HRAS—ovarian cancer	1.68e-05	0.000353	CbGpPWpGaD
Midazolam—UGT1A4—Metabolism—PIK3CG—ovarian cancer	1.67e-05	0.000351	CbGpPWpGaD
Midazolam—ABCB1—Integrated Pancreatic Cancer Pathway—CASP3—ovarian cancer	1.67e-05	0.00035	CbGpPWpGaD
Midazolam—ABCB1—Transmembrane transport of small molecules—SLC2A1—ovarian cancer	1.65e-05	0.000347	CbGpPWpGaD
Midazolam—CYP3A4—Metabolism—NME2—ovarian cancer	1.63e-05	0.000342	CbGpPWpGaD
Midazolam—ABCB1—Integrated Pancreatic Cancer Pathway—CCND1—ovarian cancer	1.62e-05	0.000341	CbGpPWpGaD
Midazolam—ABCB1—Integrated Pancreatic Cancer Pathway—CTNNB1—ovarian cancer	1.61e-05	0.000337	CbGpPWpGaD
Midazolam—SLC22A1—Neuronal System—MAPK1—ovarian cancer	1.6e-05	0.000337	CbGpPWpGaD
Midazolam—ABCB1—Integrated Pancreatic Cancer Pathway—PTEN—ovarian cancer	1.56e-05	0.000329	CbGpPWpGaD
Midazolam—GABRA1—Neuronal System—HRAS—ovarian cancer	1.5e-05	0.000316	CbGpPWpGaD
Midazolam—CYP3A7—Metabolism—FASN—ovarian cancer	1.49e-05	0.000313	CbGpPWpGaD
Midazolam—ABCB1—Metabolism—PPP1CC—ovarian cancer	1.49e-05	0.000312	CbGpPWpGaD
Midazolam—ABCB1—Metabolism—BRIP1—ovarian cancer	1.49e-05	0.000312	CbGpPWpGaD
Midazolam—UGT1A4—Metabolism—PIK3CD—ovarian cancer	1.47e-05	0.000308	CbGpPWpGaD
Midazolam—CYP3A7—Metabolism—SLC5A5—ovarian cancer	1.47e-05	0.000308	CbGpPWpGaD
Midazolam—CYP3A7—Metabolism—SLC2A1—ovarian cancer	1.42e-05	0.000298	CbGpPWpGaD
Midazolam—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—ovarian cancer	1.41e-05	0.000297	CbGpPWpGaD
Midazolam—SLC22A1—Metabolism—FASN—ovarian cancer	1.39e-05	0.000291	CbGpPWpGaD
Midazolam—SLC22A1—Metabolism—SLC5A5—ovarian cancer	1.36e-05	0.000287	CbGpPWpGaD
Midazolam—CYP3A7—Metabolism—CYP1B1—ovarian cancer	1.36e-05	0.000285	CbGpPWpGaD
Midazolam—CYP2B6—Metabolism—YAP1—ovarian cancer	1.35e-05	0.000284	CbGpPWpGaD
Midazolam—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK3—ovarian cancer	1.34e-05	0.000281	CbGpPWpGaD
Midazolam—CYP2E1—Metabolism—YAP1—ovarian cancer	1.32e-05	0.000278	CbGpPWpGaD
Midazolam—CYP3A5—Metabolism—YAP1—ovarian cancer	1.32e-05	0.000278	CbGpPWpGaD
Midazolam—SLC22A1—Metabolism—SLC2A1—ovarian cancer	1.32e-05	0.000277	CbGpPWpGaD
Midazolam—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—ovarian cancer	1.3e-05	0.000273	CbGpPWpGaD
Midazolam—SLC22A1—Neuronal System—HRAS—ovarian cancer	1.29e-05	0.00027	CbGpPWpGaD
Midazolam—UGT1A4—Metabolism—PIK3CB—ovarian cancer	1.28e-05	0.000269	CbGpPWpGaD
Midazolam—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK1—ovarian cancer	1.27e-05	0.000267	CbGpPWpGaD
Midazolam—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—ovarian cancer	1.27e-05	0.000267	CbGpPWpGaD
Midazolam—SLC22A1—Metabolism—CYP1B1—ovarian cancer	1.26e-05	0.000265	CbGpPWpGaD
Midazolam—CYP4B1—Metabolism—PIK3CA—ovarian cancer	1.25e-05	0.000262	CbGpPWpGaD
Midazolam—CYP3A7—Metabolism—PPP2R1A—ovarian cancer	1.2e-05	0.000253	CbGpPWpGaD
Midazolam—ABCB1—Integrated Pancreatic Cancer Pathway—KRAS—ovarian cancer	1.2e-05	0.000253	CbGpPWpGaD
Midazolam—SLC22A1—Metabolism—PPP2R1A—ovarian cancer	1.12e-05	0.000235	CbGpPWpGaD
Midazolam—CYP3A7—Metabolism—ABCB1—ovarian cancer	1.12e-05	0.000235	CbGpPWpGaD
Midazolam—UGT1A4—Metabolism—PTEN—ovarian cancer	1.1e-05	0.000232	CbGpPWpGaD
Midazolam—ABCB1—Integrated Pancreatic Cancer Pathway—PIK3CA—ovarian cancer	1.1e-05	0.000232	CbGpPWpGaD
Midazolam—CYP2B6—Metabolism—FASN—ovarian cancer	1.1e-05	0.000232	CbGpPWpGaD
Midazolam—CYP3A7—Metabolism—TYMS—ovarian cancer	1.1e-05	0.000231	CbGpPWpGaD
Midazolam—CYP2B6—Metabolism—SLC5A5—ovarian cancer	1.08e-05	0.000228	CbGpPWpGaD
Midazolam—CYP2E1—Metabolism—FASN—ovarian cancer	1.08e-05	0.000227	CbGpPWpGaD
Midazolam—CYP3A5—Metabolism—FASN—ovarian cancer	1.08e-05	0.000226	CbGpPWpGaD
Midazolam—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—ovarian cancer	1.07e-05	0.000224	CbGpPWpGaD
Midazolam—CYP2E1—Metabolism—SLC5A5—ovarian cancer	1.06e-05	0.000223	CbGpPWpGaD
Midazolam—CYP3A5—Metabolism—SLC5A5—ovarian cancer	1.06e-05	0.000223	CbGpPWpGaD
Midazolam—CYP3A4—Metabolism—CYTB—ovarian cancer	1.05e-05	0.00022	CbGpPWpGaD
Midazolam—CYP2B6—Metabolism—SLC2A1—ovarian cancer	1.05e-05	0.00022	CbGpPWpGaD
Midazolam—SLC22A1—Metabolism—ABCB1—ovarian cancer	1.04e-05	0.000219	CbGpPWpGaD
Midazolam—CYP2E1—Metabolism—SLC2A1—ovarian cancer	1.03e-05	0.000216	CbGpPWpGaD
Midazolam—CYP3A5—Metabolism—SLC2A1—ovarian cancer	1.02e-05	0.000215	CbGpPWpGaD
Midazolam—SLC22A1—Metabolism—TYMS—ovarian cancer	1.02e-05	0.000215	CbGpPWpGaD
Midazolam—CYP4B1—Metabolism—AKT1—ovarian cancer	1.02e-05	0.000214	CbGpPWpGaD
Midazolam—CYP2B6—Metabolism—CYP1B1—ovarian cancer	1e-05	0.000211	CbGpPWpGaD
Midazolam—ABCB1—Metabolism—YAP1—ovarian cancer	9.97e-06	0.00021	CbGpPWpGaD
Midazolam—CYP2E1—Metabolism—CYP1B1—ovarian cancer	9.83e-06	0.000207	CbGpPWpGaD
Midazolam—CYP3A5—Metabolism—CYP1B1—ovarian cancer	9.81e-06	0.000206	CbGpPWpGaD
Midazolam—CYP3A4—Metabolism—BRIP1—ovarian cancer	9.16e-06	0.000193	CbGpPWpGaD
Midazolam—CYP3A4—Metabolism—PPP1CC—ovarian cancer	9.16e-06	0.000193	CbGpPWpGaD
Midazolam—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—ovarian cancer	9.02e-06	0.00019	CbGpPWpGaD
Midazolam—CYP2B6—Metabolism—PPP2R1A—ovarian cancer	8.9e-06	0.000187	CbGpPWpGaD
Midazolam—CYP3A7—Metabolism—CAV1—ovarian cancer	8.85e-06	0.000186	CbGpPWpGaD
Midazolam—CYP2E1—Metabolism—PPP2R1A—ovarian cancer	8.72e-06	0.000183	CbGpPWpGaD
Midazolam—CYP3A5—Metabolism—PPP2R1A—ovarian cancer	8.7e-06	0.000183	CbGpPWpGaD
Midazolam—CYP2B6—Metabolism—ABCB1—ovarian cancer	8.27e-06	0.000174	CbGpPWpGaD
Midazolam—SLC22A1—Metabolism—CAV1—ovarian cancer	8.23e-06	0.000173	CbGpPWpGaD
Midazolam—ABCB1—Metabolism—FASN—ovarian cancer	8.13e-06	0.000171	CbGpPWpGaD
Midazolam—CYP2B6—Metabolism—TYMS—ovarian cancer	8.12e-06	0.000171	CbGpPWpGaD
Midazolam—CYP2E1—Metabolism—ABCB1—ovarian cancer	8.1e-06	0.00017	CbGpPWpGaD
Midazolam—CYP3A5—Metabolism—ABCB1—ovarian cancer	8.08e-06	0.00017	CbGpPWpGaD
Midazolam—CYP3A7—Metabolism—PIK3CG—ovarian cancer	8.06e-06	0.000169	CbGpPWpGaD
Midazolam—ABCB1—Metabolism—SLC5A5—ovarian cancer	8e-06	0.000168	CbGpPWpGaD
Midazolam—CYP2E1—Metabolism—TYMS—ovarian cancer	7.95e-06	0.000167	CbGpPWpGaD
Midazolam—CYP3A5—Metabolism—TYMS—ovarian cancer	7.94e-06	0.000167	CbGpPWpGaD
Midazolam—UGT1A4—Metabolism—PIK3CA—ovarian cancer	7.79e-06	0.000164	CbGpPWpGaD
Midazolam—ABCB1—Metabolism—SLC2A1—ovarian cancer	7.72e-06	0.000162	CbGpPWpGaD
Midazolam—SLC22A1—Metabolism—PIK3CG—ovarian cancer	7.5e-06	0.000158	CbGpPWpGaD
Midazolam—ABCB1—Metabolism—CYP1B1—ovarian cancer	7.4e-06	0.000156	CbGpPWpGaD
Midazolam—CYP3A7—Metabolism—PIK3CD—ovarian cancer	7.08e-06	0.000149	CbGpPWpGaD
Midazolam—SLC22A1—Metabolism—PIK3CD—ovarian cancer	6.59e-06	0.000139	CbGpPWpGaD
Midazolam—ABCB1—Metabolism—PPP2R1A—ovarian cancer	6.57e-06	0.000138	CbGpPWpGaD
Midazolam—CYP2B6—Metabolism—CAV1—ovarian cancer	6.54e-06	0.000137	CbGpPWpGaD
Midazolam—CYP2E1—Metabolism—CAV1—ovarian cancer	6.41e-06	0.000135	CbGpPWpGaD
Midazolam—CYP3A5—Metabolism—CAV1—ovarian cancer	6.39e-06	0.000134	CbGpPWpGaD
Midazolam—UGT1A4—Metabolism—AKT1—ovarian cancer	6.37e-06	0.000134	CbGpPWpGaD
Midazolam—CYP3A7—Metabolism—PIK3CB—ovarian cancer	6.17e-06	0.00013	CbGpPWpGaD
Midazolam—CYP3A4—Metabolism—YAP1—ovarian cancer	6.14e-06	0.000129	CbGpPWpGaD
Midazolam—ABCB1—Metabolism—TYMS—ovarian cancer	5.99e-06	0.000126	CbGpPWpGaD
Midazolam—CYP2B6—Metabolism—PIK3CG—ovarian cancer	5.96e-06	0.000125	CbGpPWpGaD
Midazolam—CYP2E1—Metabolism—PIK3CG—ovarian cancer	5.84e-06	0.000123	CbGpPWpGaD
Midazolam—CYP3A5—Metabolism—PIK3CG—ovarian cancer	5.82e-06	0.000122	CbGpPWpGaD
Midazolam—SLC22A1—Metabolism—PIK3CB—ovarian cancer	5.75e-06	0.000121	CbGpPWpGaD
Midazolam—CYP3A7—Metabolism—PTEN—ovarian cancer	5.34e-06	0.000112	CbGpPWpGaD
Midazolam—CYP2B6—Metabolism—PIK3CD—ovarian cancer	5.24e-06	0.00011	CbGpPWpGaD
Midazolam—CYP2E1—Metabolism—PIK3CD—ovarian cancer	5.13e-06	0.000108	CbGpPWpGaD
Midazolam—CYP3A5—Metabolism—PIK3CD—ovarian cancer	5.12e-06	0.000108	CbGpPWpGaD
Midazolam—CYP3A4—Metabolism—FASN—ovarian cancer	5.01e-06	0.000105	CbGpPWpGaD
Midazolam—SLC22A1—Metabolism—PTEN—ovarian cancer	4.97e-06	0.000104	CbGpPWpGaD
Midazolam—CYP3A4—Metabolism—SLC5A5—ovarian cancer	4.93e-06	0.000104	CbGpPWpGaD
Midazolam—ABCB1—Metabolism—CAV1—ovarian cancer	4.83e-06	0.000101	CbGpPWpGaD
Midazolam—CYP3A4—Metabolism—SLC2A1—ovarian cancer	4.76e-06	0.0001	CbGpPWpGaD
Midazolam—CYP2B6—Metabolism—PIK3CB—ovarian cancer	4.57e-06	9.6e-05	CbGpPWpGaD
Midazolam—CYP3A4—Metabolism—CYP1B1—ovarian cancer	4.56e-06	9.59e-05	CbGpPWpGaD
Midazolam—CYP2E1—Metabolism—PIK3CB—ovarian cancer	4.47e-06	9.4e-05	CbGpPWpGaD
Midazolam—CYP3A5—Metabolism—PIK3CB—ovarian cancer	4.46e-06	9.38e-05	CbGpPWpGaD
Midazolam—ABCB1—Metabolism—PIK3CG—ovarian cancer	4.4e-06	9.24e-05	CbGpPWpGaD
Midazolam—CYP3A4—Metabolism—PPP2R1A—ovarian cancer	4.05e-06	8.5e-05	CbGpPWpGaD
Midazolam—CYP2B6—Metabolism—PTEN—ovarian cancer	3.95e-06	8.29e-05	CbGpPWpGaD
Midazolam—CYP2E1—Metabolism—PTEN—ovarian cancer	3.86e-06	8.12e-05	CbGpPWpGaD
Midazolam—ABCB1—Metabolism—PIK3CD—ovarian cancer	3.86e-06	8.12e-05	CbGpPWpGaD
Midazolam—CYP3A5—Metabolism—PTEN—ovarian cancer	3.86e-06	8.1e-05	CbGpPWpGaD
Midazolam—CYP3A7—Metabolism—PIK3CA—ovarian cancer	3.76e-06	7.91e-05	CbGpPWpGaD
Midazolam—CYP3A4—Metabolism—ABCB1—ovarian cancer	3.76e-06	7.89e-05	CbGpPWpGaD
Midazolam—CYP3A4—Metabolism—TYMS—ovarian cancer	3.69e-06	7.75e-05	CbGpPWpGaD
Midazolam—SLC22A1—Metabolism—PIK3CA—ovarian cancer	3.5e-06	7.36e-05	CbGpPWpGaD
Midazolam—ABCB1—Metabolism—PIK3CB—ovarian cancer	3.37e-06	7.08e-05	CbGpPWpGaD
Midazolam—CYP3A7—Metabolism—AKT1—ovarian cancer	3.07e-06	6.46e-05	CbGpPWpGaD
Midazolam—CYP3A4—Metabolism—CAV1—ovarian cancer	2.97e-06	6.25e-05	CbGpPWpGaD
Midazolam—ABCB1—Metabolism—PTEN—ovarian cancer	2.91e-06	6.12e-05	CbGpPWpGaD
Midazolam—SLC22A1—Metabolism—AKT1—ovarian cancer	2.86e-06	6.01e-05	CbGpPWpGaD
Midazolam—CYP2B6—Metabolism—PIK3CA—ovarian cancer	2.78e-06	5.85e-05	CbGpPWpGaD
Midazolam—CYP2E1—Metabolism—PIK3CA—ovarian cancer	2.73e-06	5.73e-05	CbGpPWpGaD
Midazolam—CYP3A5—Metabolism—PIK3CA—ovarian cancer	2.72e-06	5.72e-05	CbGpPWpGaD
Midazolam—CYP3A4—Metabolism—PIK3CG—ovarian cancer	2.71e-06	5.69e-05	CbGpPWpGaD
Midazolam—CYP3A4—Metabolism—PIK3CD—ovarian cancer	2.38e-06	5e-05	CbGpPWpGaD
Midazolam—CYP2B6—Metabolism—AKT1—ovarian cancer	2.27e-06	4.78e-05	CbGpPWpGaD
Midazolam—CYP2E1—Metabolism—AKT1—ovarian cancer	2.23e-06	4.68e-05	CbGpPWpGaD
Midazolam—CYP3A5—Metabolism—AKT1—ovarian cancer	2.22e-06	4.67e-05	CbGpPWpGaD
Midazolam—CYP3A4—Metabolism—PIK3CB—ovarian cancer	2.08e-06	4.36e-05	CbGpPWpGaD
Midazolam—ABCB1—Metabolism—PIK3CA—ovarian cancer	2.05e-06	4.31e-05	CbGpPWpGaD
Midazolam—CYP3A4—Metabolism—PTEN—ovarian cancer	1.79e-06	3.77e-05	CbGpPWpGaD
Midazolam—ABCB1—Metabolism—AKT1—ovarian cancer	1.68e-06	3.52e-05	CbGpPWpGaD
Midazolam—CYP3A4—Metabolism—PIK3CA—ovarian cancer	1.26e-06	2.66e-05	CbGpPWpGaD
Midazolam—CYP3A4—Metabolism—AKT1—ovarian cancer	1.03e-06	2.17e-05	CbGpPWpGaD
